People · Operator
Named in public records as an officer, director or promoter · active 2013–2026 · Biotechnology, Other Health Care, Pharmaceuticals, Biotech / Pharma, Other, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocular Therapeutix, Inc | — | Biotechnology | Series B | $81.0M | $1.5B | 2013 |
| United Vision Partners Holdings, Llc | — | Other Health Care | Series C | $44.1M | $1.0B | 2017 |
| Surface Ophthalmics, Inc. | — | Other Health Care | Series B | $40.1M | $422.4M | 2021 |
| Harrow Health, Inc. | — | Pharmaceuticals | Series A | $29.2M | $226.5M | 2016 |
| TearLab Corp | — | Other Health Care | Series A | $23.5M | $35.3M | 2015 |
| Vinci Pharmaceuticals, Inc. | — | Biotech / Pharma | Series B | $21.2M | $76.8M | 2026 |
| iOR Holdings, Inc. | — | Other Health Care | Series A | $18.0M | $8.7M | 2022 |
| CorneaGen Inc. | — | Other Health Care | Series A | $17.0M | $40.4M | 2016 |
| Iantech, Inc. | — | Other Health Care | Series A | $12.2M | $246.7M | 2017 |
| Encore Vision, Inc. | — | Other | Series A | $9.8M | $68.1M | 2014 |
| Lightfield Medical, Inc. | — | Healthtech | Seed | $6.1M | $9.2M | 2024 |
| TherOptix, Inc. | — | Other | Series A | $5.5M | $83.2M | 2019 |
| Lentechs LLC | — | Other Health Care | Seed | $5.1M | $12.0M | 2020 |
Richard Lindstrom at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Lindstrom on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard L Lindstrom | 4 | 8 |
| Adrienne Graves | 3 | 6 |
| Tyler Stowater | 2 | 7 |
| Charles Warden | 2 | 5 |
| Mark Baum | 2 | 4 |
| Monty Montoya | 2 | 2 |
| Teresa F. Sparks | 1 | 30 |
| FARHAD KHOSRAVI | 1 | 14 |
| William Link | 1 | 11 |
| Paul Finnegan | 1 | 11 |
| Alan Crane | 1 | 9 |
| Brian Levy | 1 | 8 |
| Amarpreet Sawhney | 1 | 8 |
| Brian Walsh | 1 | 7 |
| Brad Beasecker | 1 | 6 |
| Paul Karpecki | 1 | 6 |
| James Garvey | 1 | 6 |
| Tsontcho Ianchulev | 1 | 5 |
| Steven Cagnetta | 1 | 5 |
| J. Andy Corley | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.